Spontaneous remissions

A spontaneous remission of cancer is the sudden disappearance of a cancer; and all its signs, and symptoms, and markers, without any medical intervention. In the practice of modern medicine, it was, and sometimes still is, one of the great taboos. In the past, reports of spontaneous remission of cancer were often dismissed as a misdiagnosis. To hear a doctor talk about spontaneous remission is like hearing a hunter relating a tale of one of the mythical beasts, like the Yeti, or the Sasquatch, or the Loch Ness monster – "it simply doesn't happen!" Today, there are so many bonafide reports of spontaneous remission of cancer being verified, and conclusively shown to exist, without any recognized beneficial medical explanation, that the phenomena of spontaneous remissions is reluctantly being accepted by the medical community to exist. In fact, if anyone goes to PubMED[1], one of the largest medical publication repositories in the world, they can find thousands of publications verifying the phenomena of spontaneous remissions of cancer, for hundreds of cancers[2]. But don't get too excited and try to depend on the spontaneous remission phenomena alone as a solution for anyone with an individual cancer. The rates are typically very low, less than 1% or 2%. None the less, they exist. And almost no one has put any serious effort into finding out why?

And this surprises us at Reveal Therapies. Not only do spontaneous remissions happen, the fact that THEY DO HAPPEN, is of such immense importance, we at Reveal cannot understand why so many physicians and researchers have expressed so little interest in the mechanisms behind spontaneous remissions. If you ask the average cancer doctor (Oncologist) if the body can handle cancer, the answer is "No. It can't". But the existence of the spontaneous remission says "YES!" The fact that it DOES happen, no matter how rarely, means the body DOES have some means to deal with cancer! Thus, the key to attacking and defeating cancer may lie in finding out where the immune system is failing in person sick with cancer; and, where it is working in the patient with a spontaneous remission.

Recently, the scientific world of the cancer community was shocked by two studies on breast cancer. Conventional thinking held that breast cancer always gets worse once a woman has it. This has been held as a "true" statement, going back 50 years. Not anymore! In Norway, two groups of 100,000 women were analyzed, they differed only in the fact that one group was screened for breast cancer, the other was not. It was expected that the breast cancer numbers in both groups would be the same. In reality, the screened group suffered a 22% higher incidence of breast cancer. The implication of this was truly astounding! This means that perhaps as high as 1-in-5 breast cancers had undergone some form spontaneously remission, and simply "went away" in the unscreened group.

Skeptics abounded. The American Cancer Society said ""Their [Norwegian scientists] simplification of a complicated issue is both overreaching and alarming." What should have been greeted as, at the very least, profoundly interesting new data, was almost wholly ignored in a knee-jerk reaction to one of the sacred cows of medical dogma being gored. On the heels the Norwegian study came another Swedish study, started 10 years earlier, with a study group of 75,000 patients. We won't bore you with the details here[3]. The results were the same as the Norwegian study[4]. In fact, in a follow-up analysis by Dr. P.H.Zahl, presented at the 2010 Breast Cancer Symposium, his abstract said: "…the analyses [of] this Swedish data set give similar results; the increased incidence … is mainly explained by the detection of tumors that … would have gone [away] in spontaneous regression…"

Due to the clear existence of the spontaneous remission phenomena, Reveal's developers realized that a naturally existing immulogical pathway must be present. Armed with that insight, Reveal's developers were effectively able to identify the "TRAC-EM™" and its three main areas for intervention in the immulogical pathway. These are the three primary arms of the Reveal BioPACK™.